DNA Damage Recognition via Activated ATM and p53 Pathway in Nonproliferating Human Prostate Tissue
DNA Damage Recognition via Activated ATM and p53 Pathway in Nonproliferating Human Prostate Tissue
复制标题
DOI:
10.1158/0008-5472.can-10-0937
复制
发表时间:
2010-11-01
期刊:
影响因子:
11.2
通讯作者:
Laiho, Marikki
中科院分区:
文献类型:
--
作者:
Jaamaa, Sari;af Hallstrom, Taija M.;Laiho, Marikki
DNA damage response (DDR) pathways have been extensively studied in cancer cell lines and mouse models, but little is known about how DNA damage is recognized by different cell types in nonmalignant, slowly replicating human tissues. Here, we assess, using ex vivo cultures of human prostate tissue, DDR caused by cytotoxic drugs (camptothecin, doxorubicin, etoposide, and cisplatin) and ionizing radiation (IR) in the context of normal tissue architecture. Using specific markers for basal and luminal epithelial cells, we determine and quantify cell compartment-specific damage recognition. IR, doxorubicin, and etoposide induced the phosphorylation of H2A.X on Ser(139) (gamma H2AX) and DNA damage foci formation. Surprisingly, luminal epithelial cells lack the prominent gamma H2AX response after IR when compared with basal cells, although ATM phosphorylation on Ser(1981) and 53BP1 foci were clearly detectable in both cell types. The attenuated gamma H2AX response seems to result from low levels of total H2A. X in the luminal cells. Marked increase in p53, a downstream target of the activated ATM pathway, was detected only in response to camptothecin and doxorubicin. These findings emphasize the diversity of pathways activated by DNA damage in slowly replicating tissues and reveal an unexpected deviation in the prostate luminal compartment that may be relevant in prostate tumorigenesis. Detailed mapping of tissue and cell type differences in DDR will provide an outlook of relevant responses to therapeutic strategies. Cancer Res; 70(21); 8630-41. (C)2010 AACR.